Fewer Teens on Facebook – Good News for Pharma
Active US users of Facebook have declined 7.37% in the last six months and the average age of a Facebook user in 2012 was...
Is FDA Doing DTC, Social Media, & Professional Market Research On Behalf of the...
The FDA is planning on spending $364,588 to field the "Healthcare Professional Survey of Prescription Drug Promotion" (see "FDA Gets Go-Ahead for Study of...
U.S. e-Detailing Spending Up 74% in 2012. Yet Pharma Still NOT “Digitally Mature.”
According to the latest Promotion Audit by Cegedim Strategic Data (CSD), the U.S. pharmaceutical industry increased its professional digital marketing spending by 65% from...
Get Social, #GetFit and Get Healthy
A conversation with Angel Gonzalez, Founder & CEO, Ideagoras, and Veronica Botet, Global Manager, Digital and Social Media, GE Healthcare. The discussion focuses on the #GetFit initiative, a worldwide competition and social media campaign designed to raise public awareness about cancer prevention.
Mobile Medical App Guidance & Beyond!
This article is a review of an interview of Bradley Merrill Thompson, Member of the Firm at Epstein Becker & Green and General Counsel to the mHealth Regulatory Coalition. It covers the prospects for FDA's final guidance on regulation of MMAs and other regulatory issues that the mobile health community and FDA will likely face after publication of the 'final' guidelines.
Pharma Marketing News Vol. 12, No. 4: 17 April 2013
Welcome to Volume 12, Issue #4 (17 April 2013) of Pharma Marketing News.
The FDA Director Man Who Cried “Soon!”
There once was an FDA-OPDP Director man who was besieged whenever he spoke to conference attendees and the press. “When will you publish the...
FDA’s Abrams Repeats Same Old (Empty) Promises Regarding the Issuing of Social Media Guidance
According to a Pharmalot headline, FDA's Tom Abrams -- who heads the Office of Prescription Drug Promotion -- promises that "Long-Awaited Social Media...
Rare Disease Sufferers in US Worse Off Financially & Medically Than Those in UK
An interesting Shire Pharmaceutical survey compares the health, psycho-social, and economic impact of rare diseases on patient and medical communities in the United States...
Pharma Sales Jobs Take A(nother) Tumble! Digital’s Slow But Relentless Impact.
Two stories in today's Wall Street Journal caught my attention. The first article reported that Eli Lilly will lay off 30% of its U.S....
